Mannkind reported $15.36M in Gross Profit on Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Biocryst Pharmaceuticals BCRX:US USD 72.21M 6.93M
Eli Lilly And LLY:US USD 5.75B 391.2M
Halozyme Therapeutics HALO:US USD 161.66M 43.24M
Insmed INSM:US USD 54.26M 5.43M
JAZZ PHA JAZZ:US USD 806.99M 1.68M
Karyopharm Therapeutics KPTI:US USD 35.16M 3.58M
MacroGenics MGNX:US USD 38.59M 14.99M
Mannkind MNKD:US USD 15.36M 9.39M
Merk MRK:US USD 10.47B 610M
Novo Nordisk A Fs NVO:US DKK 39.83B 1.46B
Peregrine Pharmaceuticals PPHM:US USD 4.15M 4.97M
Pfizer PFE:US USD 14.47B 2.08B